Simon, M., Hanrott, K., Budd, D. C., Torres, F., Grünig, E., Escribano-Subias, P., . . . Rosenkranz, S. (2022). An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension. Pulmonary circulation, 12(1), . https://doi.org/10.1002/pul2.12024
Chicago-Zitierstil (17. Ausg.)Simon, Marc, et al. "An Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of GSK2586881 in Participants with Pulmonary Arterial Hypertension." Pulmonary Circulation 12, no. 1 (2022). https://doi.org/10.1002/pul2.12024.
MLA-Zitierstil (9. Ausg.)Simon, Marc, et al. "An Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of GSK2586881 in Participants with Pulmonary Arterial Hypertension." Pulmonary Circulation, vol. 12, no. 1, 2022, https://doi.org/10.1002/pul2.12024.